The Leukemia Research Foundation is currently funding New Investigator grants only.
The amount is up to $100,000
The grant period is one year
Funding cycle begins on July 1, 2018

Applicants are not required to be U.S. citizens. Research projects undertaken outside the U.S. will be considered. If you have further questions after reading these guidelines please see the Frequently Asked Questions. If you have questions after consulting the FAQ please contact our Research Grants Administrator.

Return to top

Preference given to proposals that focus on leukemia, lymphoma and MDS.
New Investigators are considered to be within seven (7) years of their first independent position. Years as a resident physician, fellow physician, or post-doctoral fellow are considered to be training years. Questions regarding eligibility should be directed to our Research Grants Administrator.
Adjustments for career interruptions can be made. These could include but are not limited to, family leave, military service, major illness or injury. It is the responsibility of the applicant to point out and document such interruptions.
Investigators at the instructor level or similar position must include a letter from the department chair confirming their independence. The letter should also describe the facilities and resources available to the applicant.
Applicants with an NIH KO8 or K23 are eligible.

DOE, DOD, NSF, R21, or other grants with less than $175,000 per year in total direct costs are permitted. (Multiple grants with less than $175,000 per year in total direct costs are permitted.)
NIH RO1 funding, VA Merit Award or equivalent.
Career development awards from other national foundations (ACS, ASH, Burroughs Wellcome, Kimmel Scholar, etc.).
Any single grant of $175,000 or greater in total direct costs per year.
Renewal applications will not be accepted.